Skip to main content
. 2022 Oct 26;6(11):e794. doi: 10.1097/HS9.0000000000000794

Figure 5.

Figure 5.

Principal component analysis of plasma protein biomarker profiles of healthy individuals and cHL patients before and after treatment. The plasma protein biomarker profiles of all healthy individuals and patients at various time points are depicted. Data points are computationally clustered based on covariance. BL = baseline; cHL = classical Hodgkin lymphoma; EoT = end of treatment; FU = follow-up 6 months after EoT; Healthy = healthy individuals; PC = principal component.